Parkinson's Alliance Urges Expansion of NHI Coverage for Better Disease Management
The Parkinson Alliance of Taiwan highlighted the restrictive criteria of the National Health Insurance (NHI) for treatments like carbidopa and levodopa extended-release tablets, which are crucial for managing 'freezing' in Parkinson's disease patients. With over 2,000 new diagnoses annually in Taiwan, the alliance calls for expanded coverage to improve patient care, especially in the middle to late stages of the disease.
重點整理
More than 2,000 people in Taiwan are diagnosed with Parkinson’s disease each year.
The NHI criteria for treatments like carbidopa and levodopa extended-release tablets are limited, leading to many patients at risk of 'freezing'.
Early-stage Parkinson’s can be managed with medication and lifestyle adjustments, while middle to late-stage can be dangerous due to 'freezing'.
The Parkinson Alliance of Taiwan urges the government to expand NHI coverage to better support Parkinson’s patients.